Jean-Christophe P Harmange

USPTO Granted Patents = 57 (Patent Applications = 18)

CIPO Patents = 6 (Patent Applications = 8)

EPO Patents = 24 (Patent Applications = 25)

Average Co-Inventor Count = 7.8

ph-index = 12

Forward Citations = 674(Granted Patents)

Forward Citations (Not Self Cited) = 619(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Saint Germain En Laye, FR (1998)
Cambridge, MA (US) (2019)
Andover, MA (US) (2000 - 2023)

Company Filing History:

Constellation Pharmaceuticals, Inc.

Eisai Company, Limited

Eisai R&d Management Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

Areas of Expertise:

Imidazodiazepinediones

Pyridazinones

LSD1 Inhibitors

Bromodomain Inhibitors

Histone Demethylase Inhibitors

Fused Heterocyclic Derivatives

Macrocyclic Compounds

Protein Kinase Inhibitors

Therapeutic Compounds

Nitrogen-Containing Heterocycles

Substituted Amide Derivatives

Pyrazolo Compounds

57 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12466834 - Imidazodiazepinediones and methods of use thereof (2025-11-11),

2. 12435078 - Pyridazinones and methods of use thereof (2025-10-07),

3. 11623930 - Imidazodiazepinediones and methods of use thereof (2023-04-11),

4. 11046690 - Pyridazinones and methods of use thereof (2021-06-29),

5. 10654850 - Pyridazinones and methods of use thereof (2020-05-19),

6. 10577350 - Crystalline forms of (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (2020-03-03),

7. 10526287 - LSD1 inhibitors and uses thereof (2020-01-07),

8. RE47428 - Modulators of methyl modifying enzymes, compositions and uses thereof (2019-06-10),

9. 10301253 - Therapeutic compounds and uses thereof (2019-05-28),

10. 10035801 - Pyrazolo compounds and uses thereof (2018-07-31),

11. 10022354 - Pyrrolidine amide compounds as histone demethylase inhibitors (2018-07-17),

12. 10016405 - Modulators of methyl modifying enzymes, compositions and uses thereof (2018-07-10),

13. 9980952 - Modulators of methyl modifying enzymes, compositions and uses thereof (2018-05-29),

14. 9969716 - Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof (2018-05-15),

15. 9745305 - Modulators of methyl modifying enzymes, compositions and uses thereof (2017-08-29),

Title: The Innovative Journey of Jean-Christophe P Harmange

Introduction:

Jean-Christophe P Harmange is a visionary inventor based in Andover, MA (US) known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Jean-Christophe P Harmange holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights:

With a career spanning over two decades, Jean-Christophe P Harmange has worked with leading tech companies, research institutions, and universities to bring his inventions to life. His commitment to pushing the boundaries of technology has earned him recognition as a pioneer in his field.

Collaborations:

Throughout his career, Jean-Christophe P Harmange has collaborated with top engineers, scientists, and designers to develop cutting-edge solutions that have the potential to revolutionize industries and improve the quality of life for people around the world.

Conclusion:

Jean-Christophe P Harmange's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs. His impact on the world of technology is truly remarkable, and his legacy will undoubtedly endure for years to come.

This text is generated by artificial intelligence and may not be accurate.